- Home
- » Tags
- » Medrylamine
Top View
- Marrakesh Agreement Establishing the World Trade Organization
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- FEI Prohibited Substances List
- Birla Institute of Technology & Science-Pilani, Hyderabad
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- Final20october2009versionoflist 13 November 2009
- Customs Tariff - Schedule
- 2019 Equine Prohibited Substances List
- (12) United States Patent (10) Patent No.: US 7,906,140 B2 Bromley Et Al
- Pharmaabkommen A1 E
- FEI EPSL Controlled Medication, 30 November 2018
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
- Customs Tariff - Schedule Xxi - 1
- Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
- (12) United States Patent (10) Patent No.: US 8,703,823 B2 Salehani (45) Date of Patent: Apr
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Histamine H1-Receptor Antagonists: Antihistaminic Agents
- Euregio Laboratory Services MCP Aimed at Horses – Pharmacologic Drug Library
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- United States Patent (19) 11 Patent Number: 5,834,513 Ptchelintsev Et Al
- (12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
- (19) United States (12) Patent Application Publication (10) Pub
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- The Organic Chemistry of Drug Synthesis Vol 4
- The Organic Chemistry of Drug Synthesis
- Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks